This is particularly evident in cases of mortality and cardiovascular disease, where the superiority of cystatin C is most pronounced among individuals with GFRs greater than 45 mL/min/1.73 m2 [5,45,46,47,48,49]. This evidence concerns the gene CST3 and cardiovascular disorder.